| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.39B | — | +33.5% |
| Cost of Revenue | $464.5M | — | +33.2% |
| Gross Profit | $926.5M | — | +33.6% |
| R&D Expense | $534.9M | — | +13.2% |
| SG&A Expense | $128.7M | — | -38.6% |
| Operating Income | -$326.2M | — | +27.1% |
| Pre-tax Income | -$296.7M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.08B | -26.3% | -7.1% |
| Accounts Receivable | $579.7M | -55.5% | +9.3% |
| Current Assets | $3.98B | -30.7% | -16.9% |
| Total Assets | $8.55B | -6.3% | +4.9% |
| Current Liabilities | $3.78B | -14.6% | +24.6% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $243.2M | — | +6.5% |
| Capital Expenditures | $10.5M | — | -76.8% |
| Investing Cash Flow | -$604.5M | — | -979.8% |
| Financing Cash Flow | -$371.5M | — | +34.1% |
| Free Cash Flow | $232.8M | — | +26.9% |
| +30.1% |
| Income Tax | -$1.1M | — | -119.0% |
| Net Income | -$295.6M | — | +31.3% |
| EPS (Basic) | -$0.86 | — | +33.3% |
| EPS (Diluted) | -$0.86 | — | +33.3% |
| $6.61B |
| -8.2% |
| +15.2% |
| Stockholders' Equity | $1.94B | +0.8% | -19.4% |